About Cancer

HIPAA & Patient Privacy

The Cancer Institute of Dallas is committed to providing you with the highest quality of care. An essential part of this commitment is our dedication to protecting the privacy and the confidentiality of your medical information.

Our patient privacy policies have been developed in response to federal regulations that enforce the Health Insurance Portability and Accountability Act of 1996, known widely by the acronym HIPAA. The new regulations, effective April 14, 2003, set forth certain legal requirements regarding the ways healthcare providers must protect your medical information.

To comply, the Cancer Institute of Dallas must provide you with a Notice of Privacy Practices, which describes how your medical information may be used and disclosed. This notice also discusses your rights as a patient under the law.

At the Cancer Institute of Dallas, you will receive this notice the first time you seek care at the Institute or any of our physician offices or facilities, and you will be asked to sign a form acknowledging that you have received this document.

Because the new regulations apply to all healthcare providers, ours may not be the only notice you will receive. Though the format may vary, you may receive similar notices from other healthcare entities providing care or service such as doctors, pharmacies, nursing homes and healthcare plans.

For your convenience, the following is a summary of the key provisions of our notice.

The Cancer Institute of Dallas may use and disclose your medical information to:

As our patient, you have the federally protected right to:

If you have any questions or would like to report a concern or problem regarding the handling of your medical information, please contact us immediately.